{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:42:00Z","timestamp":1768434120136,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jdermsci.2017.12.017","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T17:42:06Z","timestamp":1514569326000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts"],"prefix":"10.1016","volume":"90","author":[{"given":"Soichiro","family":"Sawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritoshi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikko","family":"Kajihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Masuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2017.12.017_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002281-198901040-00011","article-title":"Immunologic aspects of scleroderma","volume":"1","author":"Korn","year":"1989","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0889-857X(21)01042-5","article-title":"Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis","volume":"16","author":"Mauch","year":"1990","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0015","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","article-title":"The transforming growth factor-\u03b2 family","volume":"6","author":"Massagu\u00e9","year":"1990","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/j.2326-5205.1989.tb00012.x","article-title":"A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor \u03b2 the answer?","volume":"32","author":"LeRoy","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","article-title":"Autocrine TGF-\u03b2 signaling in the pathogenesis of systemic sclerosis","volume":"49","author":"Ihn","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0030","first-page":"755","article-title":"Hypothesis: pathogenesis of systemic sclerosis","volume":"30","author":"Takehara","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2249.1994.tb06108.x","article-title":"IL-1 \u03b1 gene expression and protein production by fibroblasts from patients with systemic sclerosis","volume":"97","author":"Kawaguchi","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0040","first-page":"1207","article-title":"Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma","volume":"19","author":"Feghali","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0045","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar3315","volume":"13","author":"Overbeek","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.30647","article-title":"Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3","volume":"64","author":"Brissett","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","article-title":"Recent advances in IL-22 biology","volume":"23","author":"Zenewicz","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0075","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn\u2019s disease","volume":"178","author":"Wolk","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0080","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2011.01.054","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2013part II: immune cell subsets and therapeutic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-\u03b3 are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/jid.2012.463","article-title":"IL-22 promotes fibroblast-mediated wound repair in the skin","volume":"133","author":"McGee","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0100","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0105","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0110","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/anr.1780320809","article-title":"Prevalence of scleroderma spectrum disorders in the general population of South Carolina","volume":"32","author":"Maricq","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00372068","article-title":"Clinical evaluation of scleroderma spectrum disorders using a points system","volume":"284","author":"Ihn","year":"1992","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0125","doi-asserted-by":"crossref","first-page":"24666","DOI":"10.1074\/jbc.272.39.24666","article-title":"Oncostatin M stimulates transcription of the human \u03b12(I) collagen gene via the Sp1\/Sp3-binding site","volume":"272","author":"Ihn","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0130","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0135","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.38380","article-title":"Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis","volume":"66","author":"Kudo","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/kew336","article-title":"Dysregulated interleukin-23 signaling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression","volume":"56","author":"Nakayama","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0155","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","article-title":"Circulating miR-29a levels in patients with scleroderma spectrum disorder","volume":"61","author":"Kawashita","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0165","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.1100876","article-title":"TGF-\u03b2-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts","volume":"188","author":"Honda","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0170","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0180","doi-asserted-by":"crossref","first-page":"209179","DOI":"10.1155\/2013\/209179","article-title":"Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis","volume":"2013","author":"Liang","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01262327","article-title":"Increased collagen synthesis in psoriasis in vivo","volume":"287","author":"Koivukangas","year":"1995","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0190","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2017.12.017_bib0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features","volume":"55","author":"Kurzinski","year":"2011","journal-title":"Cytokine"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117310216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117310216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T08:50:59Z","timestamp":1693385459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181117310216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0923181117310216"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.017","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}